TITLE

Intercell unveils new management structure

PUB. DATE
June 2011
SOURCE
Worldwide Biotech;Jun2011, Vol. 23 Issue 6, p7
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article announces that Thomas Lingelbach was appointed as chief executive officer (CEO) at Intercell, replacing Gerd Zettlmeissl.
ACCESSION #
60963368

 

Related Articles

  • Intercell Files BLA, MAA For Encephalitis Vaccine. Sheridan, Cormac // BioWorld International;1/2/2008, Vol. 13 Issue 1, p1 

    The article reports on the success of Intercell AG to complete the biologics license application filing for its lead product, a cell-culture-based vaccine against Japanese encephalitis virus (JEV), just before Christmas of 2007. According to Gerd Zettlmeissl, CEO of Intercell, the completion is...

  • Novartis Postpones Decision on Pseudomonas Vaccine. Sheridan, Cormac // BioWorld International;4/6/2011, Vol. 16 Issue 14, p1 

    This article reports on the move of Intercell AG and Novartis AG to postpone their strategic alliance on a Pseudomonas aeruginosa vaccine in 2011. The companies made the decision until efficacy data from a trial is available. Gerd Zettlmeissl, chief executive officer (CEO) of Intercell,...

  • Intercell Gearing Up to Launch Phase III Pediatric Ixiaro Trials. Moran, Nuala // BioWorld International;12/30/2009, Vol. 14 Issue 52, p2 

    The article discusses the plans by Intercell AG to conduct two pediatric Phase III trials of its Japanese encephalitis vaccine Ixiaro. The vaccine, comprised of purified and inactivated form of the virus, received approvals from the U.S. Food & Drugs Administration (FDA), the European Medicines...

  • Aiming for Comeback, Intercell Hopes to Pad Coffers with $52M. Moran, Nuala // BioWorld International;5/9/2012, Vol. 17 Issue 19, p1 

    The article reports on an agreement signed by Intercell AG with BB Biotech AG to raise 40 million euros in debt and equity to deal with the damage done by the clinical failure of its vaccines against diarrhea and Staphylococcus aureus. Under the contract, BB Biotech will advance 20 million euros...

  • Rural hospital CEO Raymond Montgomery joins AHA board.  // AHA News;1/11/2010, Vol. 46 Issue 1, p5 

    No abstract available.

  • ON TOP.  // Business People;Apr2012, Vol. 25 Issue 4, p40 

    The article announces Fort Wayne Metals as PLANSPONSOR magazine's Plan Sponsor of the Year in the Corporate 401(k) Small category, Randal Christophel's appointment as president and CEO of the Indiana University Health Goshen and Brad Sturges of CBRE/Sturges as 2011 CBRE Top U.S. Affiliate...

  • Angela Knight to leave BBA. Tolley, Steve // Mortgage Strategy (Online Edition);4/2/2012, p8 

    The article announces that Angela Knight will leave her position as the chief executive of the British Bankers' Association.

  • Florida Grid Reliability Watchdog Names New CEO.  // Energy Daily;4/11/2012, Issue 70, p5 

    The article announces that Stacy Dochoda was appointed president and chief executive officer (CEO) of the Florida Reliability Coordinating Council Inc, which is charged with ensuring the reliability of the power supply flowing through the state's electricity grid.

  • Sobeys Appoints Poulin as CEO.  // Supermarket News Expert Blog;6/7/2012, p1 

    The article announces the appointment of Marc Poulin as president and chief executive officer (CEO) of Sobeys, a food retailing company based in Stellarton, Nova Scotia.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics